Neil McGregor

Neil R. McGregor, BDS, MDSc, PhD is a periodontist with an interest in ME/CFS research stemming from treating ME/CFS patients with temporomandibular dysfunction syndrome. He is a senior researcher at the Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, Australia and an Adjunct Professor at Victoria University, Melbourne, Australia. Dr. McGregor was a former co-editor of the Journal of Chronic Fatigue Syndrome.

Dr. McGregor is a member of the Working Group which offers their expertise and resources to the ME/CFS Collaborative Research Center at Stanford University.

Books

 * 2006, Pediatric Chronic Fatigue Syndrome by [[Kenny de Meirleir], Neil McGregor, and Elke L.S. Van Hoof]
 * 2014, Chapter Five in Advances in Clinical Chemistry, Vol. 66, published by Elsevier; "Metabolism in Chronic Fatigue Syndrome," by [[Christopher Armstrong | Christopher W. Armstrong], Neil R. McGregor, Henry L. Butt, and Paul R. Gooley]

Notable studies

 * 1996, Preliminary determination of the association between symptom expression and urinary metabolites in subjects with chronic fatigue syndrome (Abstract)
 * 1997, A Preliminary Assessment of the Association of SCL-90-R Psychological Inventory Responses with Changes in Urinary Metabolites in Patients with Chronic Fatigue Syndrome (Abstract)
 * 1998, Immunological and Haematological Parameters in Patients with Chronic Fatigue Syndrome (Abstract)
 * 2000, Investigation of Erythrocyte Oxidative Damage in Rheumatoid Arthritis and Chronic Fatigue Syndrome (Abstract)
 * 2000, The Biochemistry of Chronic Pain and Fatigue
 * 2000, Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome] (Abstract)
 * 2000, Erythrocyte Morphology in Rheumatoid Arthritis and Chronic Fatigue Syndrome: A Preliminary Study (Abstract)
 * 2002, Activity Limitations and Participation Restrictions in Patients with Chronic Fatigue Syndrome—Construction of a Disease Specific Questionnaire (Abstract)
 * 2002, Possible Triggers and Mode of Onset of Chronic Fatigue Syndrome (Abstract)
 * 2003, Monitoring a Hypothetical Channelopathy in Chronic Fatigue Syndrome: Preliminary Observations (Abstract)
 * 2003, Associations between bronchial hyperresponsiveness and immune cell parameters in patients with chronic fatigue syndrome (Abstract)
 * 2003, Comparison of Activity Limitations/Participation Restrictions Among Fibromyalgia and Chronic Fatigue Syndrome Patients (Abstract)
 * 2004, Membrane Damaging Toxins from Coagulase-Negative Staphylococcus Are Associated with Self-Reported Temporomandibular Disorder (TMD) in Patients with Chronic Fatigue Syndrome (Abstract)
 * 2004, Association Between Oxidative Damage Markers and Self-Reported Temporomandibular Dysfunction Symptoms in Patients with Chronic Fatigue Syndrome (Abstract)
 * 2007, Hematologic and urinary excretion anomalies in patients with chronic fatigue syndrome. (Abstract)
 * 2009, Increased d-lactic Acid intestinal bacteria in patients with chronic fatigue syndrome
 * 2011, The Biochemistry of Chronic Pain and Fatigue
 * 2012, NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome (Abstract)
 * 2014, Metabolism in chronic fatigue syndrome. (Abstract)
 * 2015, Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients (Abstract)
 * 2016, Widespread pain and altered renal function in ME/CFS patients (Abstract)
 * 2017, The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis/chronic fatigue syndrome (Abstract)

Talks and interviews

 * 12 Aug 2017, Community Symposium on the Molecular Basis of ME/CFS - 2017: Speech title - Genome-wide analysis & metabolome changes in ME/CFS

Online presence

 * LinkedIn
 * ResearchGate

Learn more

 * Meet the Scientists: Dr Neil McGregor